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Abstract
Risk-stratification divides the population (patients at risk of
some disease) into groups with different risks. The clinician
desires to use a risk-stratification method that achieves confi-
dent risk-stratification - the risk estimates of the different pa-
tients reflect the true risks with a high probability. This allows
him/her to use these risks to make accurate predictions about
prognosis and decisions about screening, treatments for the
current patient. We develop Risk-stratify - a two phase algo-
rithm that is designed to achieve confident risk-stratification.
In the first phase, we grow a tree to partition the covariate
space. Each node in the tree is split using statistical tests
that determine if the risks of the child nodes are different or
not. The choice of the statistical tests depends on whether
the data is censored (Log-rank test) or not (U-test). The set
of the leaves of the tree form a partition. The risk distribu-
tion of patients that belong to a leaf is different from the sib-
ling leaf but not the rest of the leaves. Therefore, some of the
leaves that have similar underlying risks are incorrectly spec-
ified to have different risks. In the second phase, we develop
a novel recursive graph decomposition approach to address
this problem. We merge the leaves of the tree that have sim-
ilar risks to form new leaves that form the final output. We
apply Risk-stratify on a cohort of patients (with no history
of cardiovascular disease) from UK Biobank and assess their
risk for cardiovascular disease. Risk-stratify significantly im-
proves risk-stratification, i.e., a lower fraction of the groups
have over/under estimated risks (measured in terms of false
discovery rate; 33% reduction) in comparison to state-of-the-
art methods for cardiovascular prediction (Random forests,
Cox model, etc.). We find that the Cox model significantly
over estimates the risk of 21,621 patients out of 216,211 pa-
tients. Risk-stratify can accurately categorize 2,987 of these
21,621 patients as low-risk individuals.
Introduction
Motivation
Risk-stratification divides the population (patients at risk of
some disease) into groups with different risks (probability of
developing a disease up to a certain time). A clinician desires
to use risk-stratification methods to estimate the risks and
arrive at reliable decisions (screening actions, interventions,
treatments). For instance, the seminal work (Fonarow et al.
2005) develops a risk-tree for mortality risk-stratification of
patients hospitalized with acutely decompensated heart fail-
ure (ADHF). This risk-tree is aimed to assist the clinician’s
decisions - low-risk patients get treated less intensively in
the telemetry ward, while high-risk patients get treated in
the intensive care unit. In cardiovascular disease (CVD),
the commonly used models for risk-stratification are the
Framingham risk score (D’Agostino Sr et al. 2001), and the
QRISK score (Lin et al. 2013). These models assist the clin-
icians with decisions regarding interventions such as anti-
platelet therapy (Baigent et al. 2009) and cholesterol low-
ering medications (See, e.g., http://qintervention.org/ which
uses QRISK score). In breast cancer, the commonly used
models for risk-stratification are the IBIS model (Tyrer,
Duffy, and Cuzick 2004), and the Gail model (Gail et al.
1989). These models are used for screening (Alaa et al.
2016) and treatment recommendations such as Tamoxifen
(Coombes et al. 2007).
The clinician expects that the risks estimated based on
these models for different patients (or at least groups of pa-
tients) reflect the true risks accurately. However, we find that
these models can fail to do so. For instance, the QRISK score
(Lin et al. 2013), which uses a Cox proportional hazards
model, overestimates the risks. We used this model to es-
timate the risks of CVD for individuals in UK Biobank data
set (Biobank 2007) (details in Motivating Example and Ex-
periments). The model significantly overestimated the risk
of 21,621 patients. This can mislead the clinicians to pre-
scribe treatments such as anti-platelet therapy, cholesterol
lowering medications, which are known to have strong side-
effects such as excess bleeding (Baigent et al. 2009), intesti-
nal problems. Therefore, it is essential to develop methods
for accurate risk-stratification.
Objective and Approach
We develop a method that stratifies the patients into groups
and achieves confident risk-stratification- the order of risk
estimates of the different groups is equal to the true order
of the risks with a high probability. We require the method
to identify a minimum number of groups such that the clini-
cians can make decisions at a refined level.
We use false discovery rate (FDR) (Shaffer 1995) - a met-
ric that measures the proportion of pairs of groups that have
very similar risks but are estimated to be very different. If
the FDR is zero, then the order of risk-estimates of differ-
ent groups is completely accurate. The challenges in achiev-
ing confident risk-stratification are i) there is an exponen-
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tially large number of ways to group the patients and a finite
amount of data; checking many possibilities simultaneously
is prone to false discoveries (Shaffer 1995), ii) it is compu-
tationally intractable to achieve the exact solution.
We developed Risk-stratify algorithm to address the
above challenges. Risk-stratify constructs a partition of the
covariate space to stratify the patients into groups. Risk-
stratify consists of two phases. In the first phase, we grow
a tree to partition the covariate space. Each node in the
tree is split along the covariate dimension that creates suffi-
ciently different risk-distributions in the child nodes. We do
not make any parametric assumptions (such as proportional-
hazards) thus we use non-parametric tests such as Log-rank
test (Mantel 1966), and U-test (Mann and Whitney 1947).
The set of the leaves of the resulting tree form a partition.
There are many leaves in the tree that have very similar
risk distributions but are estimated to be very different. In
the second phase of the algorithm, we address this problem.
We develop a novel recursive graph decomposition approach
that builds on ideas from graph-theory and hypothesis test-
ing. The procedure merges the leaves that have very similar
risk distributions to form a new partition that is close to risk-
stratified. Risk-stratify is very flexible regarding the types of
regions (non-compact) that describe a partition. Therefore,
it enables very effective risk-stratification. Risk-stratify pro-
vides interpretable partitions of the covariate space, which is
desired for the implementation in clinical practice. See Fig-
ure 1 for an overview of Risk-stratify.
Risk-stratify is applied on patients (with no history of
CVD) in the UK Biobank data set to assess their risk for
CVD. Risk-stratify significantly improves risk-stratification,
i.e., a lower fraction of the groups have over/underestimated
risks (measured in terms of FDR; 33% reduction) in compar-
ison to state-of-the-art methods for CVD prediction (Weng
et al. 2017) such as random forests, Cox model, etc.). The
Cox model significantly overestimated the risk of 21,621
patients to medium-risk (15-42 percent higher than popu-
lation risk); Risk-stratify correctly identifies 2,987 low-risk
patients out of these 21,621 patients.
Problem Formulation and Methods
Preliminaries
We consider a dataset D comprising of survival (time-to-
event) data for N patients (N = {1, .., N} is the set of
patients) who have been followed up for a finite amount
of time. Let D = {Xi, Ti}Ni=1, where Xi ∈ X is a d-
dimensional vector of covariates associated with patient i
and Ti be the observed failure time. Let T ∗i be the true fail-
ure time,Ci be the censoring time for patient i. The observed
failure time is given as Ti = min{T ∗i , Ci}. For ease of ex-
position we assume each dimension of the covariate is a bi-
nary categorical variable. However, the method extends to
non-categorical variables (See the Supplementary Material).
We define the survival distribution conditional on the covari-
ates Xi as S(t|Xi) = Pr(T ∗i > t|Xi). We use the Kaplan-
Meier estimator (Kaplan and Meier 1958) for the survival
function conditional on the covariates X ∈ X ′ ⊆ X and
denote the estimate as Sˆ(.|X ′). A set P = {X 1, ...,X k}
is a partition of X ′ if it satisfies the following conditions i)
any two regions Xm and Xn in the set P do not intersect
Xm ∩ Xn = Φ, ii) X ′ = ∪ki=1X i. Each patient X belongs
to one of the groups X j in the partition P . Define P as the
set of all the possible partitions of X .
Goal and Requirements:
Prognosis up to a given time: The clinician wants to predict
the risk - the probability of developing a disease up to a cer-
tain time t∗. We formulate the risk-stratification problem as
a search for the partition P ∈ P of the covariate space such
that the risk estimates for each region in the partition are
close to the true risks and thus can be used by the clinician
for prediction. We define the distance between the survival
distribution at time t∗ in the two regions Xm, Xn as
D(S(.|Xm), S(.|Xn)) = |S(t∗|Xm)− S(t∗|Xn)| (1)
Clinically significant separation: We say two regions
Xm and Xn have a clinically significant separation if the
difference in the risks (1) is greater than some specified
theshold ∆. For instance, ∆ = Risk10 , where Risk is the
average population risk.
Risk-Stratified Partition: If in a partition P every two
distinct regions (Xm ∈ P,Xn ∈ P , m 6= n) have a
clinically significant separation, then the partition is risk-
stratified. A risk-stratified partition P can also be understood
as a set of regions in the covariate space, which are ordered
in terms of their risks (where risks differ by at least ∆).
Maximum Risk-Stratified Partition: There can be many
risk-stratified partitions. Given a risk-stratified partition P =
{X 1, ..,X k} we can construct another risk-stratified parti-
tion P
′
= {X 1 ∪ X 2,X 3..,X k} from P . The partition P is
more desirable than than P
′
because it has more refined in-
formation. Therefore, we define the maximum risk-stratified
partition P ∗ to be the largest risk-stratified partition.
P ∗ = arg max
P
|P |
s.t. P is risk-stratified
(2)
If there are ties in (2), we select a partition that has the
largest minimum separation between all the pairs of regions.
(2) cannot be solved exactly because the underlying survival
distribution is not known. Our objective is to use the data D
to arrive at a partition that is close to P ∗. Since D is random
the output is random as well. Therefore, the problem in (2)
is stated in terms of probabilistic constraints.
Confidence level: The clinician states a confidence level
1−α and requires that the output is risk-stratified with prob-
ability at least 1− α.
Pˆ ∗ = arg max
P
|P |
s.t. P is risk-stratified with high probability
(3)
We require that Pˆ ∗ is risk-stratified with probability at
least 1 − α and it is close to P ∗ (detailed description in the
next Section). Suppose Pˆ ∗ = {X 1, ...,X 4} (∆ = 1%, α =
0.05); the risk estimates for developing the disease in 5 years
are {2%, 4%, 6%, 8%}. Since α = 0.05, in 95% of the cases,
the order of the risks discovered are accurate.
Challenges in solving (3): There are a large number of
possible partitions and a finite amount of data. Testing on
many partitions is prone to false discoveries (Shaffer 1995).
Also, (3) is computationally intractable (See Supplementary
Material). Next, we discuss a motivating example to show
how standard models fail in achieving risk-stratification.
A Motivating Example:
We consider a cohort in the UK Biobank dataset (details
in the Experiments Section), where the event is defined as
the development of CVD. We fit a Cox proportional hazards
model (used in QRISK score). Consider the two risk groups
that are identified by the Cox model: Low risk (2.5 − 4%)
group, and Medium risk (4 − 5%.). Consider two patients
one from each risk group: Subject 1 is a male, who is less
than 52 years old, with a moderate BMI (between 25 to 28),
and systolic blood pressure (below 128), with no diabetes,
no hypertension, no lipid lowering drugs, no smoking his-
tory, Subject 2 is a female, who is less than 52 years old,
with a moderate BMI (between 25 to 28), and systolic blood
pressure (between 128 to 144), with no diabetes, no hyper-
tension, no lipid lowering drugs, no smoking history. The
Cox model assigns Subject 2 to the Low-risk group (risk
score of 2.5%) and Subject 1 to the Medium-risk group (risk
score of 4%). These risk scores are the output of the esti-
mated models, but they may not reflect the true risks. We
compare the risk-distributions of the two groups based on
the survival times. Based on the hypothesis-test (U-test) that
compares the two risk groups it is found that there is no ev-
idence of a difference between the two groups (in fact both
groups have a risk of less than 2.5%). The individuals such
as Subject 1 who were assigned to risk-group 4 − 5% have
an overestimated risk and this can mislead a clinician to rec-
ommend unnecessary treatments.
Hypothesis-Testing Based Partition Search
We begin by describing a naive approach to solve (3). We use
the Kaplan-Meier estimates of the survival distributions for
every pair of regions to check for clinically significant sep-
aration. There is a serious limitation of this approach. The
empirical estimate of the distance can have a high variance.
Therefore, it is likely to identify many partitions that are
not risk-stratified as risk-stratified. We propose a hypothesis-
testing approach that overcomes the limitations of the naive
approach. We define a null hypothesis and an alternate hy-
pothesis to check risk-stratification.
• H0(P ): P is not risk-stratified
• H1(P ): P is risk-stratified
We define a hypothesis test T (D,P). The test takes the
entire dataD and the possible set of partitions P as the input
and classifies them as risk-stratified (H1(P ) is true) or not
(H0(P ) is true). The set of partitions that are classified as
risk-stratified by the test is defined as P+.
False Discovery Rate: Suppose there are multiple hypoth-
esis that are tested and some of them are declared posi-
tive. False discovery rate (Shaffer 1995) is defined as the
proportion of the false positives among the hypotheses that
were declared positive. If a partition P is tested for risk-
stratification and is declared risk-stratified (positive), then it
is equivalent to saying that |P |(|P | − 1)/2 pairs of distinct
regions in the partition are declared to have a clinically sig-
nificant separation. Suppose W of the |P |(|P | − 1)/2 com-
parisons are false positives, then the FDR(P ) is
FDR(P ) =
W
|P |(|P | − 1)/2 (4)
FDR(P ) is the fraction of pairs of regions in the partition
that have similar risks but are estimated to be very different.
We reformulate the problem in (3) in terms of constraints
on the FDR. If FDR(P ) = 0, then the partition is risk-
stratified. If FDR(P ) > 0, then the partition is not risk-
stratified. We need to ensure that the confidence level con-
straint from the clinician is met. We restrict the probabil-
ity that at least one partition, which is not risk-stratified,
is output by the test to be less than α and state the risk-
stratification problem as
P˜ = arg max
P
|P |
s.t. Pr(∪P∈P+{FDR(P ) > 0}) ≤ α, P ∈ P+
(5)
P˜ is a risk-stratified partition, i.e., the order of the esti-
mated risks of the regions in P˜ reflect the true order of the
risks, with a probability 1− α.
We now propose a test T that satisfies the constraint de-
scribed above in (5). Consider any two regions Xm ∈ P ,
Xn ∈ P , m 6= n. The dataset D is divided into these re-
gions; we denote the dataset in region Xm, Xn as Dm, Dn
respectively. We compare the distance D between the sur-
vival distributions in these two regions Xm, Xn using an
appropriate hypothesis test. If all the patients have been fol-
lowed upto time t∗, then we use the U-test, else we use log-
rank test. Define Pv(Xm,Xn,D) to be the p-value based on
the test that compares the risks in the regions Xm and Xn.
The set of partitions output by the test T is given as
P+ = {P : Pv(Xm,Xn,D) ≤ α′ ,∀Xm ∈ P,Xn ∈ P,m 6= n}
If α
′
= Γα|P |(|P |−1)|P| , then the test T described above
satisfies the constraints in (5) (See Supplementary Material
for details and value of Γ). We restate (5) in terms of the
constraint on the p-values.
P¯ = arg max
P
|P |
s.t. Pv(Xm,Xn,D) ≤ α′ ,∀Xm,Xn ∈ P,m 6= n
(6)
There are a few problems associated with directly solving
(6). The set P , in general, is very large thus the threshold
α
′
= Γα|P |(|P |−1)|P| can be very restrictive (limiting the set
of partitions that satisfy the constraint). (6) is computation-
ally intractable (See Supplementary Material). To address
the concerns about (6), we develop a greedy approach to
solve the above optimization problem.
Methods: Risk-Stratify
In this section, we describe the Risk-stratify method. The
method consists of two phases: Algorithm 1- Greedy Tree
Construction and Algorithm 2- Merge the Leaves.
Input: Survival Data, Distance metric, Confidence level
Clinically sig. separation, Minimum number of regions
Algorithm 1: Greedy tree construction 
Statistical tests: log-rank test/U-test  determine the splits
Algorithm 2: Merge the leaves
1. Map the leaves to vertices of a graph
2. Add edges: edge in the graph       similar  risks
3. Determine maximally connected components
4. Construct new subgraphs from each component: 
merge neighbors with  similar distributions
5. Recursively apply Steps 2-4 on each subgraph
MaleFemale
Age
Sex
Age
>6050-60>6050-60
MaleFemale
Age
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>6050-60>6050-60
Merge
⟹
Figure 1: Overview of Risk-Stratify
Algorithm 1- Greedy Tree Construction: We define a
function Θ that takes as input the covariate space X and out-
puts a partition Θ(X ) described as
Θ(X ) = arg max
P
|P |
s.t. Pv(Xm,Xn,D) ≤ α′ ,∀Xm,Xn ∈ P,m 6= n
|P | ≤ 2, P is composed of hypercubes
(7)
In (7), the optimization consists of two more constraints
added to (6). The first constraint restricts the size of the par-
tition to be less than or equal to two and the second con-
straint restricts the partition to be only composed of hyper-
cubes, where a hypercube is a set that can be written as
[a1, b1] × ...[ad, bd]. If there are ties, then we choose a par-
tition that minimizes the maximum of the p-values across
every pair of regions in the partition.
We use the above function (7) to develop the greedy ap-
proach in Algorithm 1. The main idea goes as follows: di-
vide the covariate space into two regions (if feasible) and
then apply the function in (7) on the generated regions in the
partition. We describe the pseudo-code for the above proce-
dure in Algorithm 1. The output of Algorithm 1 is L.
Comments on Algorithm 1: The worst case computa-
tional complexity of the Algorithm 1 is O(N3d) (See Sup-
plementary Material for the proof), where N is the number
of patients and d is the length of the covariate vector. We
control the variance in the risk-estimates in each region of
the partition by including an explicit constraint on the mini-
mum number of points in the region (See Experiments).
Limitations of Algorithm 1: In Algorithm 1, at each
split, we ensured that the two child nodes/regions that are
generated have sufficiently different risk distributions. How-
ever, there are many leaves that have similar true risks but
are estimated to be very different. In Algorithm 2, we ad-
dress this issue. In Algorithm 2, we merge the leaves that
were estimated to have very different risks (with similar true
risks) in such a way that the new merged leaves form a risk-
stratified partition and at the same time still allow the par-
tition to have a large size. In the next Section, we describe
Algorithm 2 (pseudo-code in the Supplementary Material).
Algorithm 1 Risk-stratify: Greedy Tree Construction
Fix the hyperparameter α = 0.05, α
′
= αd
Input: X
Output: L = GreedyOpt(X )
Function : GreedyOpt(Z)
Z ′ = Θ(Z)
M = Φ
If (Z ′ == Z)
M = Z
else
for Zj ∈ Z
M =M∪ GreedyOpt(Zj)
end for
end if
Function output:M
Algorithm 2- Merge the Leaves: In Algorithm 2, we
build a recursive graph decomposition approach to merge
the leaves. We provide a target number of leaves Nleaf as
a termination criterion. We summarize the key steps and the
rationale for the Steps of the Algorithm 2 below.
1. Suppose the first phase of the algorithm outputs a partition
with L regions (leaves). We create an empty graphG with
L vertices, where each vertex corresponds to a leaf in the
tree. For each vertex add an attribute called data, which
contains the survival data for the patients in the leaf.
2. For every pair of vertices in the graph G do a hypothe-
sis test (Log-rank test / U-test) and compute the p-values
associated with each pair. If a pair has a p-value higher
than the threshold α
′
, then connect it by an edge. This
step identifies all the pairs of regions/leaves output from
Algorithm 1 that share similar distributions (violate the
risk-stratification constraint). There can be many possible
ways to merge the vertices connected by the edges. We
adopt a principled approach based on the statistical sig-
nificance of the hypothesis tests.
3. Compute all the maximally connected components of the
graph G using standard breadth first search method (See
(Hopcroft and Tarjan 1973)). Consider two vertices in two
different maximally connected components. These ver-
tices have sufficiently different risks, and thus there is no
need to merge the vertices in two different components.
Hence, each component should be dealt with separately
as described in the next step.
4. We use each connected component identified in Step 3 to
create a new subgraph described as follows. We use the p-
values to identify the nearest neighbors in terms of risks.
For each vertex v in the connected component identify
the edge (v, w) associated with the highest p-value. If the
vertexw has not been already merged with another vertex,
then merge vertex v and w to form a new vertex for the
new subgraph. If the vertex w has already been merged to
form a vertex v
′
, then add the vertex v to the new vertex
v
′
. Also, add the survival data associated with the vertices
that are merged to the data attribute of each new vertex.
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Figure 2: Comparison of regions (color coded) created for
risk-stratification using different methods
5. Recursively apply the Steps 2-4 on every new subgraph
(if it is not a singleton) until the total number of vertices
(across all the subgraphs) equals Nleaf .
Comments on Algorithm 2: The worst case computa-
tional complexity of Algorithm grows as O(N3) (See the
Supplementary Material for the proof). We fixed the hyper-
parameter α
′
used in Algorithm 1 and 2 to 0.05d (See jus-
tification in Supplementary Material). Next, we provide an
illustrative example to highlight how Risk-stratify works and
the advantages offered by it in comparison to other methods.
Illustrative Example:
Consider a survival data set, where each patient has two
covariates x1, x2 (x1 indicates whether the patient is obese
or not, x2 indicates if the patient had menopause or not).
The clinician is interested in stratifying the probability of
developing cancer in 5 years and requires to identify (at
least) 2 risk-stratified groups with a separation of ∆ = 5%.
Define three risk groups low-risk 0 − 10%, medium-risk
10 − 20%, high-risk > 20%. We assume the survival dis-
tributions (based on (Lophatananon et al. 2017)) are
S(t|(x1, x2)) =
{
5
1+t if x1 ⊕ x2 = 0
10
1+2t if x1 ⊕ x2 = 1
(8)
where ⊕ is the XOR operation. For the above model we
know the exact solution to (2), (0, 0) and (1, 1) should be
in medium-risk group since the true risk is 16% and (0, 1)
and (1, 0) should be in low-risk group since the true risk
is 9%. We simulate the data from the above model. In Fig-
ure 2, we plot the 2-dimensional feature space. Cox models
use linear functions to model the impact of covariates on the
hazard rate. The Cox model divides the covariate space into
three regions, where (0, 1) is low-risk , (0, 0) and (1, 1) as
medium-risk, and (1, 0) as high-risk. Cox model overesti-
mates the risk of (1, 0). In this case FDR = 1/3.
Survival tree models (Bou-Hamad et al. 2011) construct
partitions where each region of the partition is a hypercube.
We grow a survival tree with four leaves. The risk estimates
output from a survival tree for each of the leaves are (0, 0)-
Medium-risk, (1, 1)- High-risk , (1, 0) - Low-risk , (0, 1) -
Low-risk. Survival tree overestimates the risk of (1, 1). In
this case the FDR = 1/3.
Algorithm 1 in Risk-stratify outputs the same four re-
gions as described by the survival tree. Algorithm 2 in Risk-
stratify merges the regions that are similar in survival dis-
tributions. Risk-stratify arrives at the correct risk-stratified
groups namely: (0, 0) and (1, 1) into the low-risk group,
(1, 0) and (0, 1) into the group medium-risk group. In this
case, FDR = 0. This example illustrates that Risk-stratify
allows complex regions (non-compact) to represent the par-
tition. Both Cox model and Survival tree overestimate the
risks and can mislead the clinician to prescribe unnecessary
treatments such as Tamoxifen.
Before we describe the experiments we give another ex-
ample of a distance metric D where stratification is useful.
Risk-stratification of the entire survival distributions:
The clinician wants to estimate the entire survival distribu-
tion. In this case, use the distance between the entire survival
distributions in the two regions Xm, Xn defined as
D
(
S(.|Xm), S(.|Xn)) = ∫ ∞
0
|S(τ |Xm)− S(τ |Xn)|dτ
(9)
In the above setting, we use Risk-stratify with log-rank test.
Experiments
In this section, we describe the experiments conducted (in
the R programming language) to evaluate Risk-stratify.
Dataset: UK Biobank recruited half a million partici-
pants aging 40-69 between 2006-2010. The patients were
invited for an initial assessment visit. The health records
for these patients (Hospital Episodes) were linked with UK
Biobank. In our experiments, the event is the development of
Cardiovascular Disease (CVD). We use the covariates that
have been used in the clinical literature (Hippisley-Cox et
al. 2007) and (Weng et al. 2017) for CVD prediction. The
covariates that we use are: i) Sex, ii) Age, iii) Body Mass
Index (BMI), iv) Systolic Blood Pressure, v) History of Di-
abetes, vi) Smoking Status, vii) Lipid lowering drug status,
viii) Anti-hypertensive drug status. We include all the pa-
tients who have no history of CVD. The total number of
patients that are included are 432, 225 and 3.5% of these
patients have a CVD event.
Data Preprocessing: We convert the continuous variables
(age, blood pressure, BMI) into discrete variables, which
are encoded as categorical variables. Divide each continu-
ous variable value into three groups - Low, Medium, High,
where Low is < 33 percentile values, Medium is 33 − 66
percentile values, and High is > 66 percentile.
Requirements: We evaluate Risk-stratify in two different
evaluation setups.
Evaluation Setup 1: The distance is measured between
the survival probability at the time of interest (as defined in
(1)), where t∗ = 5 years. For every patient we know if they
develop CVD at five years or not (no effect of censoring).
Evaluation Setup 2: The distance is measured between
the entire survival-distributions (9) (impacted by censoring).
The population is at an average (5 years) risk of 3.5%
and clinician specifies ∆ = 0.5%, which is a reasonable
choice (a group with risk 4% is at a 15 percent higher risk
than average risk). We set the minimum number of regions
in the partition Nleaf = 10. In the evaluation setup 1 and
Table 1: Comparing Risk-stratify for stratifiying survival
probabilities at 5 years. 0.01 < p ≤ 0.05∗, p ≤ 0.01∗∗.
Method FDR %± 95% CI # of groups
Risk-stratify 8.7 ± 2.8 13.3
CART 12.9 ± 5.1∗ 13.3
Linear Classifier 13.4 ± 1.1∗∗ 13.3
Logistic Classifier 12.7 ± 1.5∗ 13.3
XGBoost 13.3 ± 2.0∗ 13.3
Random Forest 14.1 ± 1.5∗∗ 13.3
2, we use U-test and log-rank test respectively. We set the
confidence level 1− α = 0.95.
Metrics and Cross-Validation based Evaluation: There
is a trade-off between the FDR and the size of the partition
(See (5)). We compare the FDR across different methods by
fixing the size of the partition to be the same across different
methods. We divide the data randomly into two equal splits.1
We run the methods on the first half and compute the parti-
tion. Every method outputs a partition, and our goal is to
compute the FDR defined in (4) on out of sample data. The
numerator, i.e. the true positives in FDR (4) is not known.
Therefore, we estimate the out of sample FDR. We do a pair-
wise comparison between every region in the partition that
is output by a method. If the p-value is below the adjusted
significance level (adjustment based on Bonferroni correc-
tion (Shaffer 1995)), then the comparison is declared to be a
true positive, else it is declared to be a false positive. We re-
peat the cross-validation procedure and compute the average
of the FDR estimates across ten different runs. In the Sup-
plementary Material, we establish a relationship between the
estimate of FDR computed using this procedure and the true
FDR in (4) to justify our choice for estimating FDR.
Benchmarks for Evaluation Setup 1-risk-stratification
for survival probabilities at 5 years Classification and re-
gression tree (CART) are natural candidates for comparison
with Risk-stratify for Evaluation Setup 1 (no impact of cen-
soring). We build the classification tree (RPART package)
and we control the number of leaves to be equal to the num-
ber of regions output by Risk-stratify. We also implemented
standard linear and logistic regression (glm function) to have
a comparison with standard baselines. We also compare with
random forest (randomforest package) and xgboost (xgboost
package), which are the state-of-the-art machine learning
methods for CVD prediction (Weng et al. 2017). We used
standard settings for the hyperparameters of these methods.
We create partitions for the linear, logistic, random forest,
and xgboost models as follows. Fix the number of regions in
the partition to be the same as in Risk-stratify. Divide the cu-
mulative distribution of the risk scores that are output from
these models into regions (low to high risk) such that every
region has the same number of patients. (Further details in
Supplementary Material)
Benchmarks for Evaluation Setup 2- stratification of
the entire survival distributions Survival trees are the nat-
1We use equal splits and not highly unbalanced splits because
otherwise out-of-sample data may not even have sufficient values
or any values at all in the partition identified.
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Figure 3: Risk stratification tree from Risk-stratify
All subjects: 216,211
Overestimated by Cox: 21,621
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estimated by Risk-stratify: 2,987
Figure 4: Illustrating risk-stratification gains
ural candidates to compare with Risk-stratify for Evalua-
tion Setup 2 (censoring present). We build the survival tree
(RPART package) and we control the number of leaves to
be equal to the number of regions output by Risk-stratify.
We also compare with proportional hazards survival models-
Cox model and Weibull regression (survival package). These
models provide a natural way to stratify the survival distribu-
tions, which is not true of non-proportional hazards model.
We use the proportional hazards term that depends on the
covariates to construct the partitions (we use the procedure
described for linear, logistic, randomforest and xgboost in
the previous paragraph).
Comparisons: In Table 1, we show the comparisons for
the Evaluation Setup 1 with distance in (1). Risk-stratify
achieves an FDR of 8.7%. The second best method logis-
tic classifier has an FDR 12.7% (33% reduction). In Table
2, we show the comparisons for the Evaluation Setup 2 with
distance in (1). Risk-stratify achieves an FDR of 15.1%. The
second best method Cox regression has an FDR 18.1% (16%
Table 2: Comparing Risk-stratify for stratification of entire
survival distribution. 0.01 < p ≤ 0.05∗, p ≤ 0.01∗∗.
Method FDR %± 95% CI # of groups
Risk-stratify 15.1 ± 1.9 17.6
Cox Regression 18.1 ± 1.6 ∗ 17.6
Weibull Regression 18.1 ± 1.4∗∗ 17.6
Survival Trees 22.6 ± 2.4∗∗ 17.6
reduction). In Table 1 and 2, we carry out t-test to compare
whether the gain in the FDR is statistically significant or not
(p-values are encoded as asterisks in Tables 1 and 2).
Interpreting the FDR gains: The Cox model (second
best method in Table 2) overestimates the risks of many pa-
tients. We find a group of 21, 621 patients out of 216, 211
patients, which were assigned a high risk-score of 4 − 5%
(15-42 % higher than the average population risk), whose
true risks are < 4%. Risk-stratify correctly estimates the
risk of 2, 987 patients out of these 21, 621 patients (These
patients include Subject 1 from the motivating example).
These 2, 987 patients that were significantly overestimated
(given a risk of 4%) by the Cox model (while their true risks
are < 2.5%). See Figure 4.
Visualization and Interpretation In Figure 3, we show
the tree output by Risk-stratify. The merged leaves (with
similar risks) are shown in the same color. Risk-stratify par-
titions the covariate space into interpretable regions unlike
other methods (Details in Supplementary Material).
Related Works
Survival Models
Non-Parametric Models- i) Censored Data: Survival tree
based methods (Bou-Hamad et al. 2011) grow the tree based
on statistical tests such as the log-rank test. The leaves of the
tree partition the entire covariate space. The partition that
is output from the survival trees does not satisfy the risk-
stratification constraint. Each leaf represents a region with
risks that are different from the sibling leaf but not the rest
of the leaves. Therefore, some of the leaves that have simi-
lar underlying risks are incorrectly specified to have differ-
ent risks. Survival trees are similar to Algorithm 1 in Risk-
Stratify. These works differ from ours because we have a
procedure to merge the leaves of the tree to ensure risk-
stratification of the proposed partition. See Table 3 for a
comparison of Risk-stratify with survival trees.
Ensemble based methods such as survival forests (Ish-
waran et al. 2008), Bayesian additive regression trees (Chip-
man et al. 2010) aggregate survival trees. These methods do
not output a partition of covariate space that stratifies the
survival distributions.
ii) Uncensored Data: If the survival data is uncensored,
then classification and regression trees are useful for risk-
stratification (Breiman et al. 1984) (Loh 2011). These meth-
ods are similar to survival trees and share similar limitations.
The main difference between CART and survival trees is in
the objectives used for tree growth such as Gini impurity in
comparison to test statistic. See Table 3 for a comparison of
CART with Risk-Stratify. Ensemble based methods such as
random forests, boosting methods can also be used to strat-
ify the patients (See Experiments Section). However, these
methods cannot achieve effective stratification because these
methods optimize loss functions such as accuracy, Gini im-
purity that does not necessarily guarantee that the risk es-
timates for different groups are accurate (further details in
Supplementary Material). Moreover, the partitions that are
output from these methods are not interpretable.
Semi-Parametric and Parametric models: Cox propor-
tional hazards models and other parametric proportional
Table 3: Comparing Risk-stratify, Survival Trees and CART
Survival Trees & (CART) Risk-stratify
Goal Goal
Partition the population Partition the population
into homogenous groups into risk-stratified groups
Method Method
Recursive partitioning Recursive partitioning
Algorithm 1
Metrics Metrics
Test statistic (Info gain, Gini) Constraint on p-values
Goal Goal
Avoid overfitting Risk-stratification
Method Method
Cut branches Merge leaves Algorithm 2
Metrics Metrics
Size of leaf nodes Target size, p-values
Size of the branch Size of leaf nodes
hazards models such as Weibull survival regression are the
most commonly used models in survival analysis. These
models do not output a partition of the survival distribu-
tions. These models use the proportional hazards assump-
tion, which allows for the stratification of the survival dis-
tributions that is otherwise not possible in non-proportional
hazards models. These models make parametric assump-
tions that limit their stratification ability (As shown in the
Illustrative Example and Experiments Section).
Recently, there is a large body of work on phenotyping
(See (Saria and Goldenberg 2015), (Kim et al. 2017)). Prob-
abilistic mixture models (Schulam, Wigley, and Saria 2015)
(Chen, Zhang, and Xiong 2016) are commonly used in phe-
notyping and have some semblance to our work (We com-
pare with other approaches to phenotyping such as tensor
factorization in the Supplementary Material). These prob-
abilistic mixture models have also been used for survival
analysis (See (Ruhi, Sarker, and Karim 2015), (Liverani et
al. 2015)). The mixture based survival models are parametric
and require distributional assumptions on the survival time
and the link functions. These assumptions limit these mod-
els in their ability to stratify. Also, the above models, do not
guarantee that patients in different mixture components have
sufficiently different risks.
Conclusion
We developed Risk-stratify a novel method for risk-
stratification. The method takes as inputs - the confidence
level associated with risk stratification and the minimum
number of groups to be created. Risk-stratify has two
phases. The first phase uses a recursive partitioning ap-
proach (based on statistical tests) to construct a tree. In the
second phase, we use a novel recursive graph decompo-
sition approach to merge the leaves of the tree to ensure
the risk-stratification constraints are met. We conduct ex-
periments on UK Biobank dataset and show that the Risk-
stratify achieves significantly better risk stratification (33%
reduction in false discovery rate, 2987 patients correctly
risk-stratified out of 21, 621 patients overestimated by Cox).
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